HTHT
BIIB icon

Hemenway Trust Hemenway Trust’s Biogen BIIB Stock Holding History

Hemenway Trust Hemenway Trust’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-8
Closed -$2K – 134
2016
Q4 		$2K Buy
+8
New +$2.37K ﹤0.01% 146
2016
Q1 		– Sell
-273
Closed -$84K – 132
2015
Q4 		$84K Buy
273
+41
+18% +$11.8K 0.02% 188
2015
Q3 		$68K Buy
232
+47
+25% +$15.5K 0.02% 191
2015
Q2 		$75K Buy
185
+87
+89% +$34.9K 0.02% 202
2015
Q1 		$41K Buy
98
+90
+1,125% +$35.5K 0.01% 206
2014
Q4 		$3K Buy
+8
New +$2.59K ﹤0.01% 188

Other funds holding BIIB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Hemenway Trust Hemenway Trust's BIIB Position: Q1 2017 in Review

Hemenway Trust Hemenway Trust sold out of Biogen (BIIB) in Q1 2017, closing a stake of 8 shares — an estimated $2K sold.

Hemenway Trust Hemenway Trust first reported a position in BIIB in Q4 2014 and held it in 6 quarters. The position peaked at $84K in Q4 2015. 1,020 funds tracked by Wall St. Rank hold BIIB as of Q1 2017.

  • Hemenway Trust Hemenway Trust reported no remaining Biogen position as of Q1 2017 after selling out during the quarter.
  • Hemenway Trust Hemenway Trust sold 8 Biogen shares in Q1 2017, an estimated $2K.
  • Hemenway Trust Hemenway Trust first reported a position in Biogen in Q4 2014 and held it in 6 quarters.
  • Hemenway Trust Hemenway Trust's Biogen position peaked at $84K in Q4 2015.
  • 1,020 funds tracked by Wall St. Rank held Biogen as of Q1 2017.

Based on Hemenway Trust Hemenway Trust's 13F filing for Q1 2017, filed 15 May 2017.